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Objecdves. This study was performed to define the importance 
of maintenal~e of oxidative metabolism as a dmcriptor and 
determinant of functionat recovery aKer re”sscutari~Kon in 
~atteots with left ventricular dvsfunrtion e,,rihutahle to chronic 
cwonsry srlery diiease. 
En&round. Althoueh mvornrdial arcumulalion of “F. 
fluomde&ygtucmo indic& 16. presenrc of tiswe ,hat is meta- 
hotk-atty active, it may no, tdeolty She% metahcdic prweses 
rcquirrd for restoration ofmyocardiot wntractitity. Exprimentat 
&dies suggest that, under conditions of irhemia and rr~erfu- 
sfw, mainlenance of mywardial oxidative metabolism is an 
lmpmtnnt metabolic determinanl 01 the capacity for funciional 
mo”wy. 
Merkods. In 16 patients positron rmision Ummgraphy was 
pprformld lo haraclerizr nyorardist perfusian (with H,“O), 
ox.daKve metahalbm (with “C-a~,&) and utilization of glucme 
(WiuI ‘“F-fluorodmxyglocose). Dysftnwtiooal but viable myoar. 
dium w? dilferentiated horn noaviabk myocardium cm Kw hasir 
of zsssmen8 of regtonal fU”cKan hefore and af,er coronary 
re”av”,m’tlntton. To define Le importslrce of rorcmsry revax”- 
larization on myaeprdizd prfwion and melabottt, kxnwgraphy 
waws repeated in II patienti &or re*awuttira,arian. 
The primary objective in restoring nutritive perfusion to 
mechanically dysfunctional myocardium in patients with 
chronic coronary artery disease is to improve the contractile 
performance of the heart. From a clinical standpoint, when 
and 69% of that in re”ctihiy dydonaioaal mywar& ,p 2 
o.rm3,. Regional “tixttton ca ghxmr nornlaed to r&mat 
prfurian in dysfuwKwa4 hut viable mywardivm was grerder 
lhan tha, in naroUt mvarardium (D < 0.01). However, in both 
gen consumpti&, a& dhjasadc pasitmit em&& towgrapl;y 
with “C-a&de, skauld facitimte Kx SnKfs&a OT Ihole pa 
tients mat likely to he&K from coronary rwax&&aKeo. 
,J Am call C&f 1992;2D:5dD-77, 
dysfunctional myocardium retains the capacity for func- 
tional recovery, it is generally considered to he nable. 
Conversely, tissue that lacks the capacity for functional 
recovery is considered to be nonviable (I). Consequently, 
the optimal selection of patients wirh left ventricular dys- 
function attributable to chronic coronary artery disease who 
can benefit roost from revascularizatron requires accurate 
diilerenti-iian of dvsfw&xxt but viable myocardium from 
nonviable myoca&wn. 
Because depressed reg,unal contractile perfom~ance sec- 
ondary to ischemia generally reflects underlying derange- 
ments of myocardial metabolism, characterization of altered 
myocardia~metabolism with positron emission tomography 
is a promising approach for detecting dysfunctional but still 
viable myocardium. Metabolism of glucose (anaerobic and 
aerobic) predominates in ischemic as opposed to well oxy- 
genated normal myocardiunl. Thw, positron emission to- 
mography with “F-Auorodcoxyglucose has been proposed 
&Y a means to delineate viable from nonviable myocardium in 
patients with coronary artery disease (2.3). In patients with 
left ventricuku dysfunction attnbutable to chronic coronary 
artery disease, persistence of myocardial utilization of glu- 
cose (reflected by the myocardial accumulation of “F- 
iluorodeoxyg!ucose) has been shown to be predictive of a 
restoration of function after revawdarization whether or not 
hvoooerfusion was oresent initiallv. However, oositron 
e&ion tomograph; with “F-fluorodeaxyglocose falsely 
oredicts tissue viaE!itv in aooroximatelv 15% to 22% of all 
&s and tissue nonvi’abilit{ ‘SC to 22%.of the time 12.3). A 
potential e::planation for the discordance is that myocardial 
accumulation of “F-fluorodeoxyglucose indicates the prey 
ence of fiswe that is metabolically active but does not 
identify specific metabolic processes required for restoration 
of myocardial contractility. Consequently, approaches that 
specifically delineate these metabolic processes might prove 
more accurate in identifymg dysfunctional but viable myo- 
cardium. 
Under physiologic conditions, myocardial oxidative me- 
tabolism is a prerequisite for contractile function (4.5). 
Results of studies (6-8) with isolated heart preparations and 
in laboratory animals and patients with recent myocardial 
infarction have demonstrated that maintenance of oxidative 
metabolism in ischemic myacardium and its enhancement 
after recanalization are likely to be the critical determinants 
of ultimate recovery of contractile performance. Analogous 
data are not yet available from studies of human subjects 
with more chronic coronary syndromes. Accordingly, the 
present study was performed to define the importance of 
maintenance of oxidative metabolism as a descriptor and 
detemtinant of the potential for functional recovery after 
revascularization in patients with left ventricular dy:fxtc- 
tion attributable to chronic coronarv artery disease. Posi- 
tron emission tomography was perfomted~to characterize 
myocardial perfusion (with H2”0) oxidative metabolism 
(with “C-acctate) and utilization of glucose (with “F- 
Ruorodeoxyglucose) in dysfunctional tissue and to differen- 
tiate viable from nonviable myocardium as verified by serial 
assessment of regional ventricular perfomxmce before and 
after coronary revascularization. 
Methods 
Patients studied. Sixteen patients (I I men and 5 women; 
mean age 59 years [rztge 30 to 691) who had left ventricular 
wall motion abnormalities secondary to angiographtcally 
documented coronary artery disease were studied. The 
clinical characteristics and angiogmphic findings of these 
patients are shown in Table I. Eleven patients ihad w&ned 
at least one myocardial infarction. the most recent occurring 
1 I days before the initial tomographic study. Because the 
kinetics of ‘sF-Ruorodeoxyglucose in the heart of patients 
with diabetes meihtus hax not yet been well characterized, 
patients with diabetec mellituc were excluded. Cardiac cath- 
eterization and selective coronary angiography followed by 
coronary revarcularization were performed in all patients. 
Twelve patients underwent coronary artery bypass grafting. 
and percutaneous transluminal coronary angioplasty was 
performed in four patients. The adequacy of revasculariza- 
tion was based on review of the operative reports or cardiac 
cathetenzation reports documenting the successful place- 
mcnt of bypass grafts to or successful balloon dilation of 
those coronary arteries subtending dyshmr+xd :sjucar- 
dium (see later). Yo P;!aid had a myocardial infarction 
between the initial and followup tomographic and wall 
motion studies. The protocol was approved by the Human 
Studies Committee and the Radioactive Drug Research 
Committee of Washington University School of Medicine. 
and written informed consent WBE obtained from each sub- 
ject. 
Assessment of ventricular function. Regional systolic 
function was assessed before and afler revascularization in 
all patients (mean time after revascularization 3.1 + 2.2 
months) (Table I). The methodology used to assess regional 
systolic function was identical to that recently described (8). 
The echocardiograms. radionuclide ventriculograms ad 
contrast left ventriculograms were analyzed by two observ- 
ers (8.9) without knowledge of the tomographic and clinical 
data who calculated an average wall motion score for each 
seentent in each studv. 
-As judgedfrom Ihr onalysir of wall motion, myocardium 
ws defined as I) normal; 2) dysfunctional but viable (ini- 
tially dysfunctional segments that exhibited improvement in 
wall motion score by at least one full grade after revascular- 
ization); or 31 nonviable (initially dysfunctional segments 
that did not exhibit improvement in wall motion score atIer 
revascularization) (8). In the one patient who underwent left 
ventricular aneurysmectomy, only those segments that were 
resected were included in the analysis of dysfunctional 
segments. As judged from gross and microscopic contimm- 
lion of extensive transmural necrosis and scarring. they were 
defined as nonviable. In patients who underwent coronary 
bypass surges, the interventricular septum was excluded 
from analysis because of potential artifact associated with 
inadequate indexing in this region. Tomographic estimates of 
perfusion and metabolism before and after myocaroial revas- 
cularization were correlated with respect to indexes of 
myocardium categorized according to systolic function. 
Tomographic assewttent of prfuslon and metabolism. 
Tomographic assessments of perfusion and metabolism were 
performed in all I6 patients a mean of 10 days (range I to 30) 
before coronary revascularination. The assessments of sys- 
tolic function were performed within 0 to I2 days (mean 2.3) 
of these tomographic studies. To define the impact of myo- 
caldial rexscuiarirsiioo oo &ona: petfusiou. onidative 
metabolism and utilization of glucose, tomography was 
repeated in II patients after revascularization (mean 2.5 
months; range I .2 to 3.4). Follow-up tomographic studies 
were not performed io the one patient who underwent left 
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venlticular ane”rysmectomy (because th? mdlally dysfunc- 
tional myocardium of interest had been resected) and in four 
other patients (because of logistic difficulties). 
The methodology used 10 mewue regional xyocordial 
perfusion, oxidadve merabolism and urilirarion hns been 
recently reported in derail (S’j. In brief, tomographic studies 
were performed with either Super PElT I or Super PETT 
IIB (10.11) with subjects in the postprandial state. An initial 
transmission scan was obtained to correct subsequent emis- 
sion scans for attenuation. Then Hz”0 (0.25 to 0.30 mCi/kg 
body weight as an intraxnous boius). “O-carbon monoxide 
(40 mCi by inhalation), “C-acetate (0.25 to 0.30 mCilkg 
intravenously) and ‘8F.Ruomdeoxyglucose (9 to IO mCi 
intravenously) were administered consecutively, with the 
appropriate list-mode data collection and time delay (to 
allow <or decay) initiated after the administration of each 
radiopharmaceutical. To ensure that each patient was in the 
same position for all data collections. position was checked 
with the use of a low energy laser and indelible marks were 
placed on the torso. The estimated radiation exposure (ex- 
pressed as the effective dose equivalent) for the two com- 
plete tomographic studies (before and after revasculariza~ 
tion) was 3.6 rents. 
Myocordiol blood pow was assessed as previously de- 
scribed (12-14) based on the images ofrelative perfusion that 
were generated by correcting the composite Hz’*0 recon- 
auction for activity emanating from the intravascular com- 
partment with the use of the composite ‘*O-carbon monox- 
ide image. iwocardial oxidative metabolism was quantified 
by d&mini& the myocardial turnover rate constant, k,, 
which delineates the clearance of “C activity from myocar- 
dium (after the administration of “C-acetate) and correlates 
closely wth regmnal myocardial oxygen consumption !15- 
17). Reeional myocardial utilization of glucose was aweseed 
based on comp&te images of relative ‘R~-fluorodeoxyglucose 
activitv obtained 45 min after the administration of the 
tracer.~ Analyses of tomographic images were performed 
with ao operator-interactive image analysis procedure dcvel- 
oped and validated in our labordlory (8). The left ventricular 
m~ocaromm wn divided into the same seven anatomic 
segments as on .he wall motion studies and Hz”0 activily, 
k, and ‘RF-flucrodeoxyglucose activity were then deter- 
mined for e;tcb segment. Segmental H,“O activity and 
‘“F-Ruorodeoxyglucose activity were normabzed. hased on 
values in those segments with highest values for H,“O and 
“F-Auorodeoxyglucore. In addition. myocardial utilization 
ofglucose was&oGzed to blood Rowwithin a segment by 
dividing normalized ‘RF-fluorodeoxyglucose activity by nor- 
malized Hzt50 activity for the same segment (IS). Values for 
perfusion. oxidative metabolism and utilization of glucose 
were charactcrizcd in normal, in dysfunctional but viable 
and in nonviable myocardium before and after coronary 
revascularization. 
Statistical analyses. Resula for continuous variables are 
presented as mean value i SD. Independent and paired 
sample values were subjected to analysis of variance and to 
I testing corrected for the number of comparisons with the 
Bonferroni method. A p value < 0.05 was considered to be 
significant. 
Results 
Segmental function. In the hearts of the 16 patients stud- 
ied, 95 segments were classified: 42 as normal. 24 as dys- 
functional but still viable and 29 a~ nonviable segments. 
Average wall motion scores before coronary revasculariza- 
tion in the two categories of dysfunctional myocardium 
exhibited impairment of contractile performance of similar 
magnitude (Fig. I). Dysfunctional but viable myocardium 
manifested an average wall motion score of 2.61 * 0.77. 
Nonviable myocardium exhibited an average wall motion 
score of 2.49 + 0.61 (p = NW. After revascularization. 
dysfunctional but viable myocardium (as defined by the 
criteria used in this study) exhtbited an average improve- 
ment in wall motion score of I.2 compared with values 
before revascularization (wall motion score after revascular- 
ization averaged 1.38 -C 0.58). After revasculwization. re- 
gional wall motion in nonviable myxn:diux did not chasge, 
as evidenced by an average v/a!1 motion score after RYBS- 
c!darization of 2.44 2 0.70. 
Estimates of perfusIon and metabolism before revaseular- 
ization. The tomographic measurements of myocardial per- 
fusion and metabolism before and after coronary revascular- 
ization are summarized in Table 2 xxd Figure 2. Examples 
we shown in Figures 3 and 4. Before revascularization, 
dysfunctional but viable myocardium exhibited perfusion 
Figure I. Hislograms with average wall motion scores (and standard 
deviatianr~ far segments containing viable and nonviable myoc~r- 
drum. betore and after coronary revascultization. Before revascu- 
larization, viable and nonviable segments exhibited similar severity 
of mechanical dysfunction. 
equivalent o 79% of that of normal myocardium (p < 0.01). 
Nonviable myocardium exhibited a similar reduction in 
perfusion. averaging 74% of that seen in normal mywardium 
(p < 0.01). 
Dysfunctional bul viable myocardium exhibited oxidative 
metabolism (k, of “C-acetate clearance) equivalent to that 
of normal myocardium (95% of nomml. p = NS). In con- 
trast. in nonviable myocardium, oxidative metabolism was 
only 66% of that in normal (p < 0.01) and 69% of that in 
reversibly dysfunctional myocardium (p c 0.033). 
Rqionol “F~uorodeaxygl~~cose activity was reduced to 
a comparable level in dysfunctional but viable and in nonvi- 
able myocardium. averaging 89% and 80% of values in 
normal myocardium. respectively (p < 0.01). Because of the 
likelihood of decreased count recowy secondary to partial 
volume effects in thinned ischemic myocardium, regional 
utilization of glucose was normalized to regional perfusion (a 
transformation that partially corrects for partial volume 
averaging). Dysfunctional but viable myocardium exhibited 
utilization of glucose normalized to relative perfusion that 
was 19% greater than that in normal myocardium (p < 0.01). 
However, nonviable myocardium also exhibited an apparent 
(but not statistically significant) augmented utilization of 
glucose relative to perfusion compared with values in normal 
myocardium. 
In both reversibly and per&em/y dysfunctional myocor- 
dim, arilbation of glucose normalized to relative perfusion 
MS mrrrMiy vuiidble. No significant differences between 
the two types of myocardium were evident. In 5 of 24 
dysfunctional but viable segments, myocardial utilization of 
glucose was >2 SD below the mean ‘8F-Auorodeoxyglucose 
activity exhibited by normal myocardium (regional “F- 
Ruorodeoxyglucose activity in these five dysfunctional seg- 
ments averaged 64% of that of normal myocardium). None 
of these live segments exhibited augmented myacardial 
utilization of glucose normalized to perfusion. In contrast, 
myocardial onidative metabolism in these segments was 
similar (k, = OX64 i 0.024 min.‘) to that in the other 
dysfunctional but viable segments as judged from results of 
studies with “C-acetate. 
The variability in fhe level of myocordinl rrrilizorion of 
glucose normalhrd ro pow exhibited by both types of 
dysfunctional myocardium is further typified by the results 
listed in Table 3. In 5 of 29 nonviable segments, relative 
myocardial utilization of glucose normalized to perfusion 
was increased, a pattern thought to be indicative ofdysfunc- 
tional but viable myocardium. Indeed. the three highest 
ratios for relative utilization of glucose normalized to perfu- 
sion were evident in three of these segments. Nevertheless. 
in four of the five segments (including all three of the 
*i&we 2. HNograrns wrh average values bnd standard deviations) 
fw relatwe myocardiat blood Row IRWBF). oxidative metabo!ism. 
utdir&on of glucose and utilintion of glucose normailed !O 
relewe myocardiat btwd Row for segments containing normal. 
dysfunctional but viable and nonvlabte myocardium, bosh before 
and after coronary revascultiration. Coronary revascutarization 
had salutary effects on both myocardial bload Row and metawlism 
in scgmcnts containing dysfunctional but viable mycardxm. At- 
though after coronary revascuttization. perfusmo and mew.botixn 
tended to increw in segments containing nonviable myacardium. 
these segmenu sdlt exhibired impaired perfusion and metabdirm 
compared with both normal and dysfunctional but via& segmea~. 
*p < 0.01 compared with normal (before revaseutadadon). tp < 
0.003 compared with viable lbiore rewxulaization). tp > 0.05 
compared with values before revascuhrizaion. $p c 0.03 compared 
with normal (after rew.rcultizationl. b < 0.02 compared with 
vmble laker revarcultitionl. Abbreviations as in Table 2. 
Utilization of Glucose Utliation of Glucose Nanslized to RMBF 
segments with the highest values of utilization of glucose 
normalized to perfusion). myacardial oxidative metabolism 
was lower than that in any of the viable segments, demon- 
strating increased utilization of glucose relative to Row. 
Estimetes of perfusion and metabolism after revaxttlarizn- 
lion. After coronary revascularization, both perfusion and 
metabolism improved in dysfunctional but viable mywar- 
dium (Table 2. Fig. 2 and 4). Regional perfusion increased to 
85 + 10% and re&tal utilization of clucose normalized to 
perfusion decre&d to 1.0 2 0.2. both of which were 
comparable to values in normal myocardium (p < 0.05 vs. 
values before revasculariration). Despite the tendency 
toward improved wrfusion and metabolism (Table 2. Fig. 2 
and 3). nonviable myacardium continued to exhibit impaired 
perfusion and metabolism compared with that in normal 
myocardium (p < 0.03 for perfusion, oxidative metabolism 
and metabolism of glucose) or in reversibly dysfunctional 
myocardium (p < 0.02 for perfusion, oxidative metabolism 
and metabolism of glucose). 
Changes in perfusion and metabolism in both types of 
dysfunctional myocardium could not be attributed simply 
to changes in loading conditions. Heart rate. systolic blood 
pressure and rate-pressure product at the time of the 
tomographic studies performed before revascularization 
(76 + 9 bcatslmin, 128 f 23 mm Hg and 9.751 ? 2,207 beats/ 
miwmm Hg) were similar to values af*-r revasculxizarion 
(73 + IO betislmin, 127 + 23 mm Hg and 9.430 ? 2.781 
beatslmiwmm Hg: p = NS). 
Discussion 
Results of this study indicate that. among patients with 
left ventricular dysfunction attributable to chronic coronary 
artery disease who undergo either coronary Avery bypass 
surgery or coronary angioplasty, the presence of maintained 
oxidative metabolism is a descriptor and probably a critical 
detetminant of the potential for RCOWY of reeional me- 
chanical function. Ii addition, results indicate that restora- 
lion of nutritive perfusion in dysfunc:ional myocardium has 
salutary effects on myocardiai metabolism that underlie 
improved function. 
Myocardlat metabolism in relation to funetbn. Because 
metabolism ofglucose (both anaerobic and aerobic) predom- 
inates in ischemic myocardium, positron emission tontogra- 
phy with ‘BF-fluomdeoxyglucose has been proposeti (2.3) as 
a means for dikrentiating viable from nonviable myxar- 
dium in patients with coronary artery disease. Results nf 
prerious studies (2.3) in patients with left ventricular dys- 
function attributable to chronic coronary artcry disasc 
showed that the persistence of myocardial utilization of 
glucose identified those segments of dysfunctional myocar- 
dium that retained the capacity for recovery of systolic 
function after revascularization. Conversely, the absence of 
myocardial utilization of glucose in dysfunctional myocw 
dial segments before revascularizatian WE indicative of 
tissue that lacked the trmtetential for recovery of function. 
However. the use of this asuroach underestimated tissue 
viability 15% to 25% of th’e’ time and overestimated the 
extent of viable myocardium in 8% to 22% of all cases (2.3). 
The discordance may be related to the relative nonspecificity 
of kinetics of mvocardial ‘SF-Ruorodeoxvducase that reflect 
only overall mywarlial utilization of $&se (both aerobic 
and anaembic). Consequently, positron emission tomogra- 
phy wth ‘“F-fluomdeoxygh~cose may MU be sufficient to 
delineate directly those metabolic processes required fo: 
restoration of myocardial contractility. 
Under physiologic conditions, myocordinl oxidatire me- 
tabolism is II prerequisite for connacrilefuncrion. Results of 
studies employing a variety of measurements of regional 
systolic function have demonstrated a close and direct 
correlation between myocardirl oxygen consumption and 
cardiac work (4.5). Under conditions of ischemia and rep-%- 
fusion, maintenance of oxidative metabolism appears to be 
an imporiant metabolic determinant of the capacity for 
functional recovery. Taegtmeyer et al. (6) showed that in 
isolated rat beans rendered ischemic. recovery of function 
was contingent on a return ofoxidative metabolism. Similar 
obscrvatiow were made by Buxton et al. (7). who noted that 
oxidative metabolism in dog hearts (measured with positron 
emission tomography and “C..acetate) increased during the 
1st month after reperfusion in dysfunctional but viable 
myocardium. Allhough oxidawe metabolism in such seg- 
ments wa i&ally depressed Icompared with that in normal 
myocardium), it was lx deprewd than nxidative metabo- 
lism in nonviable tissue. 
The same investigators (7) showed that utilization of 
glucose (assessed with positron emission tomography and 
isF.fluorodeoxyglucosc) in dysfunctional hut viable myocar- 
dium varied with the interval of observation after the reslo- 
ration of perfusion. Similar phenomena are present in pa- 
tients with recent myocardial infarction. Using the same 
methodology as in the present study, we (8) showed that in 
patients with recent myocardial infarction (average 6 days) 
indergoing coronary revasculariwtion, &dative metabo- 
lism was significantly higher in dysfunctional but viable 
myocardium than in nonviable myocardium. In contrasl. 
utilization of gluco‘e normalized to flow was markedly 
variable. Our observations in the present study (Table 2, Fig. 
2) indicate that maintenance of oxidative metabolism may be 
&lady important in identifying the capacity for recovery 
of contractile performance in the heart of patients with lef! 
ventricular dy;function attributable to coronary syndromes 
of a more chronic nature. 
Comparison with previous studier. On first inspection. 
our findings of similar increases in metabolism of glucose 
normalized to perfusion in the two types of dysfunctional 
myocardium would appear to be discordant with results of 
previous studies, As mentioned previously, the presence of 
increased metabolism of glucose normalized to Raw was a 
metabolic pattern more typical of dysfunctional but viable 
myocardium than of nonviable myocardium (X3). However. 
in these studies. the number of dysfunctional segments 
demonstrating this metabolic pattern rather than the magni- 
tude of utilization of glucose normalized to Row was dcter- 
mined. Our data suggest that augmentation of rnyocardial 
utilization of alucose normalized to flow can be quite pro- 
nounced in nonviable myocardium and is ass&ted with 
reduced oxidative metabolism fTablc 31. These findines are 
crnsistent with augmentation of anaerobic glycolysis and the 
view that anaerobic glycolysis alone is insufficient n main- 
tain viability in the setting of a prolonged ischemic msult. 
Moreover, 5 of 24 dysfunctional but viable segments enhib- 
ited marked reductions Ln regional %4uorodeoxyglucose 
activity (and thus. regional myocardial utilization of glu- 
cose). but no increase in the utilization of glucose normal- 
ized to perfusion. Oxidative metabolism in these segments 
was comparable to that in reversibly dysfunclional seg- 
merits. Thus. alternative substrates (such as free fatty acids) 
must have been utilized to suppon sustained oridative 
metabolism. These results, taken in sum with similar ohser- 
vations in patients with recent myocardial infarction (8). 
suggest hat criteria to predict fun&al recovery based on 
measorement~ of myocardial oxidative metabolism will com- 
pare favorably with those based on estimates of myocardial 
utilization of glucose. 
Restoration of nutritive perfusion in dysfunctional but 
viable myocardium exerted salutary effects on both metab- 
olism and mechanical performance. These findings are cnn- 
sistent with those of Tamaki et al. (3), who demonstrated 
lhot in patients with left ventricular dysfunction attributable 
to chronic coronary artery disease, improvement in mechan- 
ical performance after revascularization was accompanied 
by resolution of the augmentation in myocardial metabolism 
of glucose normalized to Row that had been observed before 
revascularization. In our study, nonviable myocardium 
tended to exhibit improved perfusion and metabolism after 
revascularization, although both perfusioo sad metabolism 
remained impaired compared with values in both nomtal 
myocardium and dysfunctional but viable myocardium (Ta- 
ble 2, Fig. 2). This tendency toward improvement may 
reflect nonischemic dysfunction or “stenting” of metaboli- 
cally and functionally normal subepicardium by subjacent 
metabolically and functionally impaired subendocardium 
(19). the pr&encc of pockets of m&bolically active lissue 
interspersed with predominantly necrotic tissue, or both. 
Methndolngic onsiderations. Regional myocardial perfu- 
sion and utilization of glucose were measured in relative 
terms with respect o the regional distribution of I50 and “F 
activities. Our motto (201 and others 1211 have validated the 
accuracy of p&t& emission tomography with H,“O for 
the quantification of regional myocardial blood Row in 
absolute terms. However, in myocardium subjected to in- 
tense ischemia, quantitative estimates of perfusion are im- 
paired by limited counting statistics, partial vnlume werag- 
ing and spillover effects. To acquire realistic ertimates for 
such segments, we measured myocardial perfusion in rela- 
tive terms by positron emission tomography with H,“O. 
This approach provides accurate estimates of regional per- 
fusion, independent of the metabolic state of the lissue, over 
a wide ranee of flow rates. as iudeed from direct correlations 
with estim&es of regional ~y&ardial blood flow obtained 
with radiolabeled microspheres (I2.13). 
Recent results (22-24) have demonstrated that accurate 
quantitative estimates of overall myocardial utilization of 
glucose can be accomplished with positron emission tomog- 
raphy and “F-Ruorodeoxyglucose when Patlak graphic anal- 
ysis is employed. However, the accuracy of this approach 
for quantifyina myocardial utilization of glucose has not 
been’defmed under con&ions of severe ischemia and reper- 
fusion in which the extent of deohosohorvlation of “F- 
Ruorodeoxyglucose-6.phosphate may v&y. Significant de- 
phosphorylalion of ‘8F-Ruorodeoxyglucose-6-phosphale 
would result in the underestimation of overall myocardial 
u!iliration of glucose with the Patlak approach (22-24). 
Nevertheless, the regional distribution of myocardisl “F- 
Ruorodeoxyglucose activity 45 to613 min after administration 
of tracer provides an accurate reflection of overall, regional 
myocardial utilization of glucose (25). 
Strictly speaking. observations in this study are applica- 
ble only to &a&who do not have diabetesmellil& The 
myocardial kinetics of ‘8F-Ruorodeoxyglucose have not yet 
been fully elucidated in animals with experimentally induced 
diabetes mellitus or in patients with the disease. Although 
results OF preliminary studies indicate that myocardial im- 
ages of ‘OF-~uorodeuxyglucose activity of reasonable quality 
ten be obtained in diabetic human sub]ecrs with protocok 
that tightly control the substrate environment. the climcal 
significance of patternr of regional myocardial accumularwn 
of “F-Ruorodeoxyglucose in these patients has yet to be 
determined (26). Myocardial clearance of “C activity (after 
the administration of “C-acetale) k relativelv lmensitive to 
changes in the substrate milieu (271. C&equently. rhe 
present observation that oxidative metabolism 15 an imnor- 
fant descriptor of the capacity for functional recovery may 
be applicable in patients with diabetes mellitus. 
Clinical implications. Our results indicate that in patients 
with left ventkular dysfunction attributable to chronic 
coronary artery disease, preservation of oxidaive me&b”- 
lism is a necessary condition fur recovery of function. The 
presence of augmented myocardial utdwation of glucox 
relative 10 perfusion identifies dyrfuunclional myocardium 
that retains the capacity for recovery of contraclile perfor- 
mance only when the metabolic pattern reflects primarily 
oxidative utilization of glucose. The rerults indn.te that 
measurement of myocardial oxygen consumpliun. as with 
positron emission tomography with “C-acetate. facilitates 
the accurate identification of those parientr with lefl vemnc- 
ulw dysfunction who are likely to benefit from curonary 
revascularization. 
